Seoul National University Bundang Hospital (SNUBH)
| Corea del Sur | España | Turquía | |
| Resección de estómago | de $18,500 | de $9,000 | de $16,470 |
| Quimioterapia para el cáncer de mama | de $19,200 | de $3,500 | de $1,200 |
| Cirugía de cáncer de estómago | de $18,500 | de $25,000 | de $22,320 |
| Radioterapia para el cáncer colorrectal | - | de $10,000 | de $7,000 |
Bookimed no añade cargos extra a los precios de los tratamientos de Cáncer de estómago etapa 2. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Cáncer de estómago etapa 2 y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Cáncer de estómago etapa 2.
Stage 2 stomach cancer treatment in Korea follows a curative-intent protocol centered on gastrectomy with D2 lymphadenectomy. Surgeons remove part or all of the stomach and 15+ surrounding lymph nodes. Most patients receive adjuvant chemotherapy after surgery to ensure a 5-year survival rate of over 90%.
Bookimed Expert Insight: Data shows a major volume gap between general clinics and Korea's top centers. Asan Medical Center performs over 65,000 operations annually, while SNUBH serves 1.5 million patients. This high volume allows surgeons to master D2 lymphadenectomy, which is technically demanding but crucial for Stage 2 outcomes. For patients, this means choosing a facility that handles over 150 gastric cases yearly ensures the most standardized and safe reconstruction.
Patient Consensus: Patients emphasize the speed of Korean surgical teams and suggest preparing for strict dietary changes immediately after gastrectomy. Many recommend clarifying whether the plan is partial or total removal before the procedure starts.
Adjuvant chemotherapy is the standard of care for Stage 2 stomach cancer in Korea. Surgeons perform a gastrectomy followed by drug therapy to eliminate micro-metastases. Starting treatment within 6 weeks of surgery maximizes survival rates. Decisions depend on final pathology, including lymph node involvement and margins.
Bookimed Expert Insight: Data from Seoul National University Hospital and Severance Hospital shows high-volume centers integrate digital tracking like the BESTcare system. This technology allows metabolic monitoring during chemotherapy. High success rates at Asan Medical Center, which performs over 65,000 operations annually, often involve 52-week post-op observation cycles. Patients choosing these major Seoul centers benefit from specialized gastro-oncology teams who adjust dosages based on recovery speed.
Patient Consensus: Patients note that while surgery is the primary step, doctors often push for chemotherapy if final pathology confirms lymph node involvement. Many emphasize checking whether the stage is based on initial scans or the final surgical report before deciding.
Korean oncology centers use radiation for Stage 2 stomach cancer primarily as adjuvant therapy following surgery. It is reserved for cases with high-risk features like positive surgical margins or lymph node involvement. Dedicated teams at JCI-accredited facilities provide these treatments to prevent local recurrence.
Bookimed Expert Insight: Clinical data from Seoul National University Hospital shows a focus on aggressive D2 lymphadenectomy during surgery. This surgical precision often reduces the need for routine radiation in Stage 2 cases. Doctors prioritize this extensive node removal to achieve high survival rates without extra radiation side effects.
Patient Consensus: Patients note that radiation is rarely the first choice for Stage 2 and is only added if post-surgery biopsy results show a high risk of the cancer returning. Most people focus on finding experienced surgeons at large Seoul hospitals to ensure the cleanest possible initial resection.
South Korean clinics follow a highly structured protocol for stomach cancer stage 2 surveillance. Patients undergo diagnostic imaging and laboratory tests every 3 to 6 months during the first 2 years. The frequency typically reduces to every 6 to 12 months for the following 3 years.
Bookimed Expert Insight: Korea's top hospitals like Severance and Asan Medical Center favor a digital-first approach to surveillance. Asan Medical Center manages over 10,000 outpatients daily using streamlined protocols. Results are often available within hours. This high volume across Seoul centers ensures doctors identify even minor changes quickly. It makes the 5-year surveillance period extremely reliable.
Patient Consensus: Patients note that testing is very frequent and protocol-driven during the first few years. They find the structured schedule reassuring rather than a cause for concern.
South Korea achieves superior outcomes for Stage 2 stomach cancer through high-volume surgical specialization and standardized radical gastrectomy. Leading Seoul hospitals utilize advanced D2 lymph node dissection to prevent recurrence. National screening programs ensure early detection while surgeons maintain expertise by performing thousands of procedures annually.
Bookimed Expert Insight: The success in Korea stems from massive patient centralization in Seoul. Large hospitals like Severance manage 1.6 million outpatients annually. This concentration allows surgeons to see more Stage 2 cases in one month than others see in a year. This repetition leads to exceptionally precise nodal clearance, which is the primary factor in preventing cancer return.
Patient Consensus: Patients note that the strict follow-up schedule is vital for long-term health. They emphasize that regular endoscopy and imaging after surgery provide peace of mind during recovery.
International patients obtain a second opinion in Korea by submitting medical records to specialized international healthcare centers at JCI-accredited tertiary hospitals. Leading institutions like Asan Medical Center and Severance Hospital provide remote consultations via Zoom or written reports for stomach cancer staging and treatment planning.
Bookimed Expert Insight: Korea's medical landscape is highly centralized. Large tertiary hospitals like Asan Medical Center or Seoul National University Hospital handle massive patient volumes, with some performing over 65,000 operations annually. This immense scale means Korean oncologists often see more specific cancer subtypes in one month than others see in a year. When seeking a second opinion, focus on these high-volume university hospitals to benefit from their deep expertise in complex stomach cancer cases.
Patient Consensus: Patients emphasize the importance of requesting a complete reread of original pathology slides and imaging discs rather than just a summary. They also note that major Seoul hospitals coordinate faster when a diagnosis is already confirmed.
Recurrent stage 2 stomach cancer in South Korea is managed through surgical resection, systemic chemotherapy, and targeted immunotherapy. Specialized centers in Seoul utilize laparoscopic and robotic-assisted techniques for re-intervention. Multidisciplinary teams prioritize high-volume surgical expertise and advanced drug regimens like FLOT for optimized outcomes.
Bookimed Expert Insight: Clinical volume is a major quality signal in South Korea. Facilities like Seoul National University Bundang Hospital and Severance Hospital manage over 1.5 million outpatients annually. Asan Medical Center performs over 65,000 operations per year. This massive caseload means oncology teams encounter recurrent cases daily, leading to highly refined surgical protocols and fewer technical errors.